Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy
PainPublished 1 August 2003
Peter Watson, Dwight E. Moulin, J. Watt-Watson, Allan Gordon, John Eisenhoffer
Citations509
SJR quartileQ1
SJR score2.02
SNIP1.87
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
CR oxycodone is effective and safe for the management of painful diabetic neuropathy and improves health‐related quality of life (QOL) while receiving controlled‐release (CR) oxyCodone (OxyContin®) or active placebo.
Abstract
CR oxycodone is effective and safe for the management of painful diabetic neuropathy and improves QOL.
Keywords
Medicine
PainClinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale
5,689 Citations2001John T. Farrar, James P. Young +3 more
Using a standard outcome across chronic pain studies would greatly enhance the comparability, validity, and clinical applicability of these studies, and the application of these results to future studies may provide a standard definition of clinically important improvement in clinical trials of chronic pain therapies.
Medical CareThe MOS 36-ltem Short-Form Health Survey (SF-36): III. Tests of Data Quality, Scaling Assumptions, and Reliability Across Diverse Patient Groups
4,468 Citations1994Colleen A. McHorney, John E. Ware +2 more
BMJThe number needed to treat: a clinically useful measure of treatment effect
1,872 Citations1995Richard J. Cook, D L Sackett
The relative benefit of an active treatment over a control is usually expressed as the relative risk, the Relative risk reduction, or the odds ratio, but for clinical decision making, it is more meaningful to use the measure "number needed to treat."
JAMAGabapentin for the Symptomatic Treatment of Painful Neuropathy in Patients With Diabetes Mellitus<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
1,527 Citations1998Miroslav Bačkonja
Gabapentin monotherapy appears to be efficacious for the treatment of pain and sleep interference associated with diabetic peripheral neuropathy and exhibits positive effects on mood and quality of life.
JAMAGabapentin for the Treatment of Postherpetic Neuralgia<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
1,433 Citations1998Michael C. Rowbotham
Gabapentin is effective in the treatment of pain and sleep interference associated with PHN and Mood and quality of life also improve with gabapentin therapy.
PainEfficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action
1,144 Citations1999Søren H. Sindrup, Troels S. Jensen
It is concluded that tricyclic antidepressants in optimal doses appear to be the most efficient treatment of neuropathic pain, but some of the other treatments may be important due to their better tolerability.
New England Journal of MedicineEffects of Desipramine, Amitriptyline, and Fluoxetine on Pain in Diabetic Neuropathy
1,113 Citations1992Mitchell B. Max, Sue Lynch +4 more
Desipramine relieves pain caused by diabetic neuropathy with efficacy similar to that of amitriptyline, offering an alternative for patients unable to tolerate the latter and blockade of norepinephrine reuptake is likely to mediate the analgesic effect of these antidepressant drugs in diabetic Neuropathy.
PainA systematic review of antidepressants in neuropathic pain
934 Citations1996H J McQuay, Martin R. Tramèr +4 more
Antidepressants are effective in relieving neuropathic pain and it is still unclear which drug class should be first choice, with very similar results for anticonvulsants.
NeurologyAmitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood
701 Citations1987Mitchell B. Max, Mary Culnane +5 more
It is concluded that amitriptyline relieves pain in diabetic neuropathy; this effect is independent of mood elevation.
PubMedCanadian normative data for the SF-36 health survey. Canadian Multicentre Osteoporosis Study Research Group.
693 Citations2000Wilma M. Hopman, Tanveer Towheed +10 more
Canadian men scored substantially higher than women on all 8 domains and the 2 summary component scales of the SF-36 and scored higher than their UK counterparts on 4 domains, although many of the differences are not large.
NeurologyEfficacy of oxycodone in neuronathic pain
649 Citations1998Carolyn Watson, Najib Babul
Controlled-release oxycodone is an effective analgesic for the management of steady pain, paroxysmal spontaneous pain, and allodynia, which frequently characterize postherpetic neuralgia.
PainGabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study
593 Citations2001Andrew S.C. Rice, S. Maton
The role of gabapentin as an efficacious and well‐tolerated treatment for postherpetic neuralgia is confirmed and the most common adverse events were dizziness and somnolence, particularly during the titration phase.
PubMedThe Pain Disability Index: psychometric and validity data.
588 Citations1987Raymond C. Tait, C. Alec Pollard +3 more
The results of two studies concerning the psychometric properties and the validity of the PDI are presented and several methodologic issues are discussed, and suggestions are made for future uses of the instrument.
NeurologyDouble‐blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy
543 Citations1998Yadollah Harati, Clifton L. Gooch +9 more
The results of this placebo-controlled trial showed that tramadol was effective and safe in treating the pain of diabetic neuropathy and no statistically significant treatment effects on sleep were identified.
NeurologyBoth intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia
485 Citations1991Michael C. Rowbotham, Lori A. Reisner-Keller +1 more
The results show that neuropathic pain can respond to opioids and to systemically administered local anesthetic drugs.
New England Journal of MedicinePrevention and Treatment of the Complications of Diabetes Mellitus
372 Citations1995Charles M. Clark, D. Lee
Journal of Pain and Symptom ManagementAntidepressants and Anticonvulsants for Diabetic Neuropathy and Postherpetic Neuralgia
352 Citations2000Sally Collins, R Andrew Moore +2 more
Antidepressants and anticonvulsants had the same efficacy and incidence of minor adverse effects in these tzoo neuropathic pain conditions, and there was no evidence that selective serotonin reuptake inhibitors (SSRIs) were better than older antidepressants, andno evidence that gabapentin was better than Older anticonVulsants.
PainTramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial
317 Citations1999Søren H. Sindrup, Grethe Andersen +4 more
It is concluded that tramadol appears to relieve both ongoing pain symptoms and the key neuropathic pain feature allodynia in polyneuropathy.
PainEfficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial
302 Citations1991Mitchell B. Max, Ranganna Kishore-Kumar +5 more
Desipramine relieves pain in many patients with painful diabetic neuropathy, offering an alternative for patients unable to tolerate amitriptyline, and blockade of norepinephrine reuptake may mediate this analgesic effect.
Archives of Internal MedicineAround-the-Clock, Controlled-Release Oxycodone Therapy for Osteoarthritis-Related Pain
297 Citations2000S. Roth, Roy Fleischmann +6 more
Around-the-clock controlled-release oxycodone therapy seemed to be effective and safe for patients with chronic, moderate to severe, osteo-arthritis-related pain, and effective analgesia was accompanied by a reduction in the interference of pain with mood, sleep, and enjoyment of life.
Diabetes CareReport and Recommendations of the San Antonio Conference on Diabetic Neuropathy
284 Citations1988American Diabetes Association, American Academy of Neurology
The purpose of the conference was to assess the state of knowledge of diabetic neuropathy and to recommend a set of research guidelines for future clinical investigations, which were adopted by the conferees.
Diabetes CareDiabetic Neuropathies
281 Citations1992Aaron I. Vinik, Marie T Holland +4 more
Although unproven, the best evidence suggests that near-normal control of blood glucose in the early years after diabetes onset may help delay the development of clinically significant nerve impairment.
DiabetologiaSymptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol�): Double blind crossover trial
273 Citations1969Juan Rull, R Quibrera +2 more
Journal of Pain and Symptom ManagementControversies in the long-term management of analgesic therapy in patients with advanced cancer
273 Citations1990Russell K. Portenoy, Nessa Coyle
This review discusses some of the most important topics of pain in the patient with advanced cancer, which range from the overall system of care and quality of assessment to the specifics of pharmacotherapy and other modalities of treatment.
JAMAImipramine Treatment of Painful Diabetic Neuropathy
258 Citations1984Birgit Kvinesdal
The rating of specific symptoms at the end of each treatment period showed a beneficial effect of imipramine on pain, paresthesia, dysesthesia, numbness, and nocturnal aggravation.
Annals of Internal MedicineThe Landscape and Lexicon of Blinding in Randomized Trials
244 Citations2002Kenneth F. Schulz, Iain Chalmers +1 more
The landscape and lexicon of blinding in randomized trials in the hope of untangling some of that terminology, which is widely recognized as reducing differential assessment of outcomes of interest.
PainDeriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics
242 Citations1996Andrew Moore, Henry McQuay +1 more
Showing that dichotomous data can reliably be derived from mean data, at least in acute pain models, indicates that more meaningful overviews or meta‐analysis may be possible in systematic reviews of RCTs of analgesics.
NeurologyOpioid responsiveness of cancer pain syndromes caused by neuropathic or nociceptive mechanisms
194 Citations1994Nathan I. Cherny, Howard T. Thaler +5 more
Data from four controlled single-dose relative-potency studies support the postulate that opioid responsiveness is a continuum with extensive overlap in the responsiveness of pains mediated by neuropathic, nociceptive, and mixed pain mechanisms.
PubMedDouble blind randomized placebo control trial of controlled release codeine in the treatment of osteoarthritis of the hip or knee.
169 Citations2000P. M. Peloso, N. Bellamy +5 more
Single entity controlled release codeine is an effective treatment for pain due to OA of the hip or knee and was significantly better than placebo on measures of sleep quality and requirement for supplemental acetaminophen.
Survey of AnesthesiologyGabapentin for the Symptomatic Treatment of Painful Neuropathy in Patients With Diabetes Mellitus: a Randomized Controlled Trial
152 Citations1999Miroslav Bačkonja, Ahmad Beydoun +6 more
Gabapentin monotherapy appears to be efficacious for the treatment of pain and sleep interference associated with diabetic peripheral neuropathy and exhibits positive effects on mood and quality of life.
Clinical Pharmacology & TherapeuticsPhenytoin in the treatment of diabetic symmetrical polyneuropathy
145 Citations1977Christopher D. Saudek, S.W. Werns +1 more
It is concluded that phenytoin has no role in the treatment of diabetic symmetrical polyneuropathy, and the incidence of undesirable side effects was increased.
Journal of Pain and Symptom ManagementProlonged Treatment with Transdermal Fentanyl in Neuropathic Pain
143 Citations1998Paul L.I. Dellemijn, H. van Duijn +1 more
It is concluded that long-term transdermal fentanyl may be effective in noncancer neuropathic pain without clinically significant management problems and a FENiv-test may assist in selecting neuropathicPain patients who might benefit from prolonged treatment with FENtd.
CancerComparative clinical efficacy and safety of a novel controlled-release oxycodone formulation and controlled-release hydromorphone in the treatment of cancer pain
112 Citations1997Neil A. Hagen, Najib Babul
This study compared the clinical efficacy and safety of a novel oxycodone formulation with that of hydromorphone in the treatment of cancer pain.
European Journal of Clinical PharmacologyImipramine treatment in diabetic neuropathy: relief of subjective symptoms without changes in peripheral and autonomic nerve function
105 Citations1989Søren H. Sindrup, Bent Ejlertsen +4 more
Imipramine had a clear benificial effect on the symptoms of the neuropathy, whereas no changes in a range of neurophysiological measurements was detected.
PainInhibition of visceral pain by electrical stimulation of the periaqueductal gray matter
104 Citations1976Glenn J. Giesler, John C. Liebeskind
A visceral pain test employing intraperitoneal injection of hypertonic saline which yields a writhing response in the adult rat more reliably than other painproducing substances.
PubMedTegretol in the treatment of diabetic neuropathy.
101 Citations1974Wilton Td
Patients suffering from peripheral neuropathy caused by diabetes mellitus were admitted to a double-blind trial comparing the efficacy of Tegretol (carbamazepine) and placebo and significant relief of pain was obtained.
Diabetes CareChronic and Remitting Painful Diabetic Polyneuropathy: Correlations With Clinical Features and Subsequent Changes in Neurophysiology
74 Citations1988Robert J. Young, D J Ewing +1 more
It is suggested that remitting and chronic painful diabetic polyneuropathy have distinctive clinical features at presentation and detectable neurophysiological differences during their symptomatic evolution.
Annals of NeurologyChronic opioid therapy as alternative treatment for post-herpetic neuralgia
54 Citations1994M. Pappagallo, James N. Campbell
Observations warrant a controlled opioid trial for patients affected by PHN, and the mean pretreatment pain score, on a scale of 0 to 10 (0 = no pain), was 9.0 ± 0.3.
Annals of PharmacotherapyPeripheral Diabetic Neuropathy: Current Concepts in Treatment
52 Citations1995Piera T. Calissi, Linda A. Jaber
Treatment of PN remains unsatisfactory and therapy should be directed toward prevention with glycemic control and symptomatic treatment of existing PN, including pain and paresthesia.
Survey of AnesthesiologyGabapentin for the Treatment of Postherpetic Neuralgia: a Randomized Controlled Study
41 Citations1999Michael C. Rowbotham, Norman Harden +3 more
Pain Research and ManagementTreatment of Neuropathic Pain: Focus on Antidepressants, Opioids and Gabapentin
8 Citations1999Carolyn Watson, J. Watt-Watson
The treatment of neuropathic pain continues to be difficult and Randomized, controlled trials (RCTs) provide some evidence to guide therapy, although there is information on anticonvulsants and other treatments.